{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T02:11:05Z","timestamp":1774491065696,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmorwd.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Real World Data and Digital Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.esmorw.2025.100678","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T06:50:19Z","timestamp":1768805419000},"page":"100678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Histotype-specific incidence and survival of urothelial carcinoma\u2014an analysis of the German North Rhine-Westphalia Cancer Registry"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2532-8398","authenticated-orcid":false,"given":"C.","family":"Darr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7892-2422","authenticated-orcid":false,"given":"A.","family":"Szentkiralyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Claassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Sch\u00fcrger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hilser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Stang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.A.","family":"Hadaschik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kaj\u00fcter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2083-7687","authenticated-orcid":false,"given":"V.","family":"Gr\u00fcnwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.esmorw.2025.100678_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.esmorw.2025.100678_bib2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.eururo.2020.09.006","article-title":"Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita","volume":"78","author":"Teoh","year":"2020","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.esmorw.2025.100678_bib3","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.juro.2013.05.040","article-title":"The impact of histological reclassification during pathology re-review \u2013 evidence of a Will Rogers effect in bladder cancer?","volume":"190","author":"Linder","year":"2013","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.esmorw.2025.100678_bib4","first-page":"421","article-title":"The changing patterns of bladder cancer in Egypt over the past 26 years","volume":"19","author":"Felix","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.esmorw.2025.100678_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7308168","article-title":"Biomarkers in urachal cancer and adenocarcinomas in the bladder: a comprehensive review supplemented by own data","volume":"2018","author":"Reis","year":"2018","journal-title":"Dis Markers"},{"key":"10.1016\/j.esmorw.2025.100678_bib6","series-title":"presented at the EAU Annual Congress Madrid 2025","year":"2025"},{"issue":"35","key":"10.1016\/j.esmorw.2025.100678_bib7","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1200\/JCO.23.00307","article-title":"Definitions, end points, and clinical trial designs for bladder cancer: recommendations from the Society for Immunotherapy of Cancer and the International Bladder Cancer Group","volume":"41","author":"Kamat","year":"2023","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.esmorw.2025.100678_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.eururo.2019.10.026","article-title":"Updated results of PURE-01 with preliminary activity of neoadjuvant pembrolizumab in patients with muscle-invasive bladder carcinoma with variant histologies","volume":"77","author":"Necchi","year":"2020","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100678_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs\u2013Part A: renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.esmorw.2025.100678_bib10","series-title":"TNM Classification of Malignant Tumours","year":"2017"},{"issue":"3","key":"10.1016\/j.esmorw.2025.100678_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ijc.2910020310","article-title":"Summarizing indices for comparison of cancer incidence data","volume":"2","author":"Doll","year":"1967","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.esmorw.2025.100678_bib12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0025-6196(26)04443-5","article-title":"Calculation of survival rates for cancer","volume":"25","author":"Berkson","year":"1950","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"10.1016\/j.esmorw.2025.100678_bib13","first-page":"101","article-title":"The relative survival rate: a statistical methodology","volume":"6","author":"Ederer","year":"1961","journal-title":"Natl Cancer Inst Monogr"},{"issue":"14","key":"10.1016\/j.esmorw.2025.100678_bib14","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.ejca.2011.03.011","article-title":"Choosing the relative survival method for cancer survival estimation","volume":"47","author":"Hakulinen","year":"2011","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.esmorw.2025.100678_bib15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejca.2003.10.013","article-title":"Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications","volume":"40","author":"Brenner","year":"2004","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.esmorw.2025.100678_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.eururo.2022.07.002","article-title":"The 2022 World Health Organization classification of tumors of the urinary system and male genital organs-Part B: prostate and urinary tract tumors","volume":"82","author":"Netto","year":"2022","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.esmorw.2025.100678_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clgc.2020.07.011","article-title":"Bladder cancer: a comparison between non-urothelial variant histology and urothelial carcinoma across all stages and treatment modalities","volume":"19","author":"Deuker","year":"2021","journal-title":"Clin Genitourin Cancer"}],"container-title":["ESMO Real World Data and Digital Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949820125005673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949820125005673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T01:25:23Z","timestamp":1774488323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949820125005673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":17,"alternative-id":["S2949820125005673"],"URL":"https:\/\/doi.org\/10.1016\/j.esmorw.2025.100678","relation":{},"ISSN":["2949-8201"],"issn-type":[{"value":"2949-8201","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histotype-specific incidence and survival of urothelial carcinoma\u2014an analysis of the German North Rhine-Westphalia Cancer Registry","name":"articletitle","label":"Article Title"},{"value":"ESMO Real World Data and Digital Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmorw.2025.100678","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100678"}}